Board
Prof. Ian Frazer MD, PhD, FRCP, AC, FRS
Director & Chief Scientific Officer
Professor of Medicine UQ,
Co-inventor Gardasil vaccine.
Implicit Bioscience co-founder and director.
Prof. Peter Andrews PhD AO FTSE
Chairman
Australian biotech pioneer,
Implicit Bioscience co-founder and director.
Garry Redlich BA LLB DUniv
CEO & Managing Director
Former CEO Peplin Ltd.
Implicit Bioscience co-founder and director.
Peter Fry BSc
Director
Former president Reckitt Benckiser Pharma, Boots Pharma.
Marion Koster BSc CPA
Chief Financial Officer & Company Secretary
Former ASX-listed biotech finance head.
Management
Prof. Ian Frazer AC MBChB MD FRS
Chief Scientific Officer
Brisbane
Dr Jan Agosti MD
Chief Medical Officer
Seattle
Dr Gordon Brandt MD
Director of Regulatory Affairs
Seattle
Patrick Gearing PhD
Director CMC
Seattle
Garry Redlich BA LLB DUniv
Chief Executive Officer
Seattle, Brisbane
Marion Koster BSc CPA
Chief Financial Officer
Brisbane
David Crowe PhD
VP Research
Seattle
Mark Appleby PhD
VP Preclinical
Seattle
Philip Wallace DPhil. MBA
VP Product & Business Development
Seattle
Brian Ziegelaar PhD
VP AU Ops
Brisbane
Patrick Charmley PhD
VP Projects & Program Management
Seattle
Clinical Investigators and Advisors
Prof. Merit Cudkowicz MD
Principal Scientist, ALS/MND phase 2
Healey Center, Mass. General/Harvard
Prof. Stanley Appel MD
Senior Neuroscience Advisor
Houston Methodist/Weill Cornell
A/Prof. Ivan Zanoni PhD
Senior Immunology Advisor
Boston Children’s/Harvard
Prof. Richard J. Ulevitch PhD
Senior Target Biology Consultant
San Diego
Prof. Erica Fletcher MSc PhD
Principal Investigator, Retinal Diseases
Visual Neurosciences/UniMelb
A/Prof. Robert Henderson MBBS PhD FRACP
Principal Investigator, ALS/MND
Royal Brisbane & Women’s/UniQld
Anjan Aralihalli MSc MBA
Venture Partner CTI Life Sciences, Board member Muscular Dystrophy Association
Neuromuscular Diseases
A/Prof. Kory Lavine MD PhD
Director of Cardiovascular Precision Medicine Research Initiative, Washington University School of Medicine in St Louis
Cardio-immunology
Prof. Antonio Abbate MD PhD
Professor of Cardiology, Virginia Commonwealth University
Cardio-immunology
Professor Robyn Guymer AM, MBBS, PhD, FRANZCO, FAHMS
Deputy Director, Centre for Eye Research Australia, Professor of Surgery (Ophthalmology), University of Melbourne
Retinal Diseases
Thomas Hohman PhD
Former leader retinal translation programs at Allergan, Alcon, Novartis
Retinal Diseases
Prof. David Reutens MD FRACP
Principal Investigator, TBI/epilepsy
Centre for Advanced Imaging/UniQld
A/Prof. Lyndell Lim, MBBS, DMedSci, FRANZCO
Head, Clinical Trials Research Unit, Centre for Eye Research Australia
Retinal Diseases
George Magrath, MD MBA
CEO Lexitas Pharma Services, Inc.
Retinal Diseases